BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 29236346)

  • 21. Danazol as First-Line Therapy for Myelodysplastic Syndrome.
    Colunga-Pedraza PR; Colunga-Pedraza JE; Garza-Ledezma MA; Jaime-Pérez JC; Cantú-Rodríguez OG; Gutiérrez-Aguirre CH; Rendón-Ramírez EJ; López-García YK; Lozano-Morales RE; Gómez-De León A; Sotomayor-Duque G; Gómez-Almaguer D
    Clin Lymphoma Myeloma Leuk; 2018 Feb; 18(2):e109-e113. PubMed ID: 29268959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myeloid neoplasms post cytotoxic therapy: epidemiology, pathogenesis outcomes, prognostic factors, and treatment options.
    Ma J; Wang Y
    Ann Med; 2024 Dec; 56(1):2329132. PubMed ID: 38608646
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transformation from acute promyelocytic leukemia in pregnancy to acute myeloid leukemia with MLL-AF9 fusion gene: A case report and literature review.
    Gao Y; Han N; Jiang Y; Lu Z
    Medicine (Baltimore); 2023 Dec; 102(48):e36403. PubMed ID: 38050244
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A population-based analysis of invasive fungal disease in haematology-oncology patients using data linkage of state-wide registries and administrative databases: 2005 - 2016.
    Valentine JC; Morrissey CO; Tacey MA; Liew D; Patil S; Peleg AY; Ananda-Rajah MR
    BMC Infect Dis; 2019 Mar; 19(1):274. PubMed ID: 30898090
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidemiology and Clinical Significance of Secondary and Therapy-Related Acute Myeloid Leukemia: A National Population-Based Cohort Study.
    Granfeldt Østgård LS; Medeiros BC; Sengeløv H; Nørgaard M; Andersen MK; Dufva IH; Friis LS; Kjeldsen E; Marcher CW; Preiss B; Severinsen M; Nørgaard JM
    J Clin Oncol; 2015 Nov; 33(31):3641-9. PubMed ID: 26304885
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of treatment-related myelodysplastic syndromes and acute myeloid leukemia in patients with non-Hodgkin lymphoma treated with tositumomab and iodine I131 tositumomab.
    Bennett JM; Kaminski MS; Leonard JP; Vose JM; Zelenetz AD; Knox SJ; Horning S; Press OW; Radford JA; Kroll SM; Capizzi RL
    Blood; 2005 Jun; 105(12):4576-82. PubMed ID: 15731177
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A review of therapy-related myelodysplastic syndromes and acute myeloid leukaemia (t-MDS/AML) in Irish patients: a single centre experience.
    Maung SW; Burke C; Hayde J; Walshe J; McDermott R; Desmond R; McHugh J; Enright H
    Hematology; 2017 Jul; 22(6):341-346. PubMed ID: 28196450
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapy-related myelodysplastic syndrome and acute myeloid leukemia with 17p deletion. A report on 25 cases.
    Merlat A; Lai JL; Sterkers Y; Demory JL; Bauters F; Preudhomme C; Fenaux P
    Leukemia; 1999 Feb; 13(2):250-7. PubMed ID: 10025899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of Chemotherapy for Solid Tumors With Development of Therapy-Related Myelodysplastic Syndrome or Acute Myeloid Leukemia in the Modern Era.
    Morton LM; Dores GM; Schonfeld SJ; Linet MS; Sigel BS; Lam CJK; Tucker MA; Curtis RE
    JAMA Oncol; 2019 Mar; 5(3):318-325. PubMed ID: 30570657
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapy-related acute myeloid leukaemia and myelodysplastic syndrome in Victoria, Australia 2003-2014.
    Ong DM; Farrugia H; Wei A
    Intern Med J; 2018 Jul; 48(7):822-829. PubMed ID: 29236346
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment-related myelodysplasia and acute leukemia in non-Hodgkin's lymphoma patients.
    Armitage JO; Carbone PP; Connors JM; Levine A; Bennett JM; Kroll S
    J Clin Oncol; 2003 Mar; 21(5):897-906. PubMed ID: 12610191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Second malignancies following treatment in non-Hodgkin's lymphoma.
    Ellis M; Lishner M
    Leuk Lymphoma; 1993 Mar; 9(4-5):337-42. PubMed ID: 8348069
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.